Skip to content

Models 1S & 1P Intraocular Lens

by Alcon

PMA P800049

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

PMA P800049↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved 1 supplement NumberP800049 Date1 Oct 1985ApprovedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Full name
Models 1S & 1P
Generic Name
intraocular lens
PMA Number
FDA Product Code
HQL
Device Class
Class III
Regulation
21 CFR Part 886.3600
Advisory Committee
Ophthalmic
FDA Decision
APPR Approved
PMA Supplement
S003

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Models 1S & 1P Intraocular Lens is a posterior chamber intraocular lens designed to replace the natural crystalline lens following cataract extraction or other lens removal procedures. These lenses are intended for implantation in the eye to restore vision by focusing light onto the retina, correcting refractive errors and improving visual acuity.

These lenses are supplied sterile and intended for single-use in ophthalmic surgical settings. They are classified as Class III devices under FDA regulations (886.3600) and were authorized via a Premarket Approval (PMA P800049, Supplement S003). The Models 1S & 1P are non-MRI-conditional and must be handled with sterile techniques in a controlled surgical environment.

Other devices from Alcon

See all devices from Alcon →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Models 1S & 1P Intraocular Lens, and in which procedures is it typically used?

    The Models 1S & 1P Intraocular Lens is designed to replace the natural crystalline lens after cataract extraction or other lens removal procedures. Its purpose is to restore vision by focusing light onto the retina, correcting refractive errors, and improving visual acuity following implantation in the posterior chamber of the eye.

  • Are the Models 1S & 1P lenses single-use or reusable, and how should they be handled during surgery?

    The Models 1S & 1P lenses are intended for single-use only in sterile ophthalmic surgical settings. They are supplied sterile and must be handled using sterile techniques in a controlled environment to maintain integrity and prevent contamination.

  • What regulatory pathway was followed for the approval of these lenses, and what classification do they hold under FDA regulations?

    The Models 1S & 1P Intraocular Lenses were authorized via a Premarket Approval (PMA P800049, Supplement S003). They are classified as Class III devices under FDA regulations (886.3600), reflecting their high-risk nature and the need for rigorous pre-market evaluation.

  • Can these lenses be used in patients who require MRI scans, and why?

    No, the Models 1S & 1P lenses are non-MRI-conditional, meaning they are not safe for use in MRI environments. This is explicitly stated in the device’s specifications, and patients with these lenses should avoid MRI procedures unless specifically cleared by a radiologist or manufacturer.

  • What type of surgical setting is recommended for implantation of these lenses, and why?

    These lenses are designed for use in ophthalmic surgical settings that adhere to sterile protocols. The requirement for sterile handling and controlled environments ensures patient safety and device integrity, as contamination or improper technique could compromise outcomes.